ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Connecticut » Interventional Pain Medicine

Top Interventional Pain Medicine Prescribers in Connecticut

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PARDEEP SOOD MD

Interventional Pain Medicine

7,473

$537K

569
186 are 65+

82%
patients receiving schedule two controlled substances

Avg: 59%

21%
patients receiving schedule three controlled substances

Avg: 18%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 26%

$72
Average prescription price

Avg: $110

ROBERT BOOLBOL MD

Interventional Pain Medicine

5,292

$316K

508
148 are 65+

84%
patients receiving schedule two controlled substances

Avg: 59%

22%
patients receiving schedule three controlled substances

Avg: 18%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $110

MARK THIMINEUR MD

Interventional Pain Medicine

4,813

$915K

586
125 are 65+

86%
patients receiving schedule two controlled substances

Avg: 59%

13%
patients receiving schedule three controlled substances

Avg: 18%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 26%

$190
Average prescription price

Avg: $110

MOHAN VODAPALLY M.D.,DABPM

Interventional Pain Medicine

2,729

$312K

200
90 are 65+

79%
patients receiving schedule two controlled substances

Avg: 59%

16%
patients receiving schedule three controlled substances

Avg: 18%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 26%

$114
Average prescription price

Avg: $110

ANNETTE MACANNUCO-WINSLOW M.D.

Interventional Pain Medicine

2,601

$227K

299
183 are 65+

63%
patients receiving schedule two controlled substances

Avg: 59%

33%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 26%

$87
Average prescription price

Avg: $110

VINCENT CARLESI M.D.

Interventional Pain Medicine

2,033

$451K

143
67 are 65+

74%
patients receiving schedule two controlled substances

Avg: 59%

16%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 26%

$222
Average prescription price

Avg: $110

JONATHAN KOST M.D.

Interventional Pain Medicine

1,678

$196K

197
100 are 65+

65%
patients receiving schedule two controlled substances

Avg: 59%

24%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 26%

$117
Average prescription price

Avg: $110

DAVID LEVI MD

Interventional Pain Medicine

1,266

$109K

328
178 are 65+

52%
patients receiving schedule two controlled substances

Avg: 59%

23%
patients receiving schedule three controlled substances

Avg: 18%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 26%

$86
Average prescription price

Avg: $110

MICHELLE NISENBAUM MD

Interventional Pain Medicine

774

$87.9K

128
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 59%

9%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 26%

$114
Average prescription price

Avg: $110

JACOB RAUCHWERGER MD

Interventional Pain Medicine

482

$52.8K

107
59 are 65+

62%
patients receiving schedule two controlled substances

Avg: 59%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 26%

$109
Average prescription price

Avg: $110

ERIC GRAHLING MD

Interventional Pain Medicine

250

$16.5K

78
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 59%

19%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 26%

$66
Average prescription price

Avg: $110

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank